Your account is not claimed yet. You can sign up with ORCID to claim your account.

Antonio Mazzocca

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Venues

International journal of molecular sciences

Medical oncology (Northwood, London, England)

ChemMedChem

Journal of molecular medicine (Berlin, Germany)

Universita degli Studi di Bari Aldo Moro (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Universita degli Studi di Bari Aldo Moro

Italy

PHD :: Dipartimento Interdisciplinare di Medicina (DIM)

Publications

Davide Gnocchi, Carlo Sabbà, Mara Massimi, Antonio Mazzocca
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy. International journal of molecular sciences 24 (4) (2023)
Davide Gnocchi, Carlo Sabbà, Mara Massimi, Antonio Mazzocca
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy. International journal of molecular sciences 24 (4) (2023)
Davide Gnocchi, Dragana Nikolic, Rosa Rita Paparella, Carlo Sabbà, Antonio Mazzocca
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis. Cancers 15 (15) (2023)
Davide Gnocchi, Carlo Sabbà, Mara Massimi, Antonio Mazzocca
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy. International journal of molecular sciences 24 (4) (2023)
Davide Gnocchi, Marta B Afonso, Maria Maddalena Cavalluzzi, Giovanni Lentini, Giuseppe Ingravallo, Carlo Sabbà, Cecilia M P Rodrigues, Antonio Mazzocca
Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice. Molecular carcinogenesis (2023)
Davide Gnocchi, Carlo Sabbà, Mara Massimi, Antonio Mazzocca
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy. International journal of molecular sciences 24 (4) (2023)
Davide Gnocchi, Carlo Sabbà, Mara Massimi, Antonio Mazzocca
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy. International journal of molecular sciences 24 (4) (2023)
Vinicio Carloni, Elisa Morganti, Andrea Galli, Antonio Mazzocca
The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance. International journal of molecular sciences 24 (1) (2022)
Vinicio Carloni, Elisa Morganti, Andrea Galli, Antonio Mazzocca
The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance. International journal of molecular sciences 24 (1) (2022)
Vinicio Carloni, Elisa Morganti, Andrea Galli, Antonio Mazzocca
The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance. International journal of molecular sciences 24 (1) (2022)
Rosa Divella, Gennaro Gadaleta Caldarola, Antonio Mazzocca
Chronic Inflammation in Obesity and Cancer Cachexia. Journal of clinical medicine 11 (8) (2022)
Matteo Lulli, Laura Del Coco, Tommaso Mello, Caecilia H C Sukowati, Stefania Madiai, Laura Gragnani, Paolo Forte, Francesco Paolo Fanizzi, Antonio Mazzocca, Krista Rombouts, Andrea Galli, Vinicio Carloni
DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer. Cancer research 81 (11) (2021)
Davide Gnocchi, Maria M Cavalluzzi, Giuseppe F Mangiatordi, Rosanna Rizzi, Cosimo Tortorella, Mauro Spennacchio, Giovanni Lentini, Angela Altomare, Carlo Sabbà, Antonio Mazzocca
Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth. ChemMedChem 16 (13) (2021)
Michele Barone, Alfredo Di Leo, Carlo Sabbà, Antonio Mazzocca
The perplexity of targeting genetic alterations in hepatocellular carcinoma. Medical oncology (Northwood, London, England) 37 (8) (2020)
Davide Gnocchi, Gianluigi Cesari, Generosa Jenny Calabrese, Roberto Capone, Carlo Sabbà, Antonio Mazzocca
Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum L. Plant foods for human nutrition (Dordrecht, Netherlands) 75 (1) (2020)
Antonio Mazzocca
The Systemic-Evolutionary Theory of the Origin of Cancer (SETOC): A New Interpretative Model of Cancer as a Complex Biological System. International journal of molecular sciences 20 (19) (2019)
Davide Gnocchi, Saketh Kapoor, Patrizia Nitti, Maria Maddalena Cavalluzzi, Giovanni Lentini, Nunzio Denora, Carlo Sabbà, Antonio Mazzocca
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function. Journal of molecular medicine (Berlin, Germany) 98 (2) (2019)
Antonio Mazzocca, Luca Maria Schönauer, Rosalba De Nola, Antonio Lippolis, Teresa Marrano, Matteo Loverro, Carlo Sabbà, Edoardo Di Naro
Autotaxin is a novel molecular identifier of type I endometrial cancer. Medical oncology (Northwood, London, England) 35 (12) (2018)

Antonio Mazzocca.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Antonio Mazzocca